Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 424 of 684

Advanced search

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide

NewsNationOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Nearly 100 people sickened in salmonella outbreak linked in part to recalled eggs produced in Texas: FDA

ABC7 New YorkOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

DCGI Gives Go-Ahead for Phase III Trial of Zydus' Desidustat in Sickle Cell Disease

Medical DialoguesOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Merck unveils early global access plan for monthly HIV prevention pill ahead of phase 3 completion

Indian Pharma PostOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Selinexor for myelofibrosis or a drug in search of a disease?

NatureOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

The Bull Case For Takeda Pharmaceutical (TSE:4502) Could Change Following New Zasocitinib Phase 3 Psoriasis Data

simplywall.stOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Beijing SL Pharmaceutical Co. Ltd. Class A – SZSE:002038

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Afghanistan, Uzbekistan Pledge to Bolster Healthcare & Pharmaceutical Partnership

باختر خبري اژانسOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

What Just Happened with Day One Biopharmaceuticals and Servier

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class A – SSE:603207

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Is the FDA Poised to Reshape the Peptide Market

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class A – SSE:603207

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Is Arcturus Therapeutics' ARCT-032 a Game Changer for Cystic Fibrosis

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Large BMJ Study Confirms GLP-1 Drugs Like Ozempic and Mounjaro Are Linked to a Real Hair Loss Risk

Medical DailyOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Commercial Trade's Expanding Mandate: From Product Movement to Commercial Performance

Pharmaceutical CommerceOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Chinese Ambassador to Zimbabwe, Zhou Ding, visits China-aided Zimbabwe National Pharmaceutical Warehouse

The Sun NigeriaOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Biotech Growth Trust PLC Revenue Breakdown – LSE:BIOG

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Iran, India agree to facilitate medical and pharmaceutical cooperation at BRICS meeting

IRNA EnglishOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

US Court Rules FDA Abortion Pill Restrictions Unlawful, Orders Review of Mifepristone Rules

BarristerNG.comOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Summit Therapeutics Reports Positive Phase 3 Trial Data for Ivonescimab

sekbernews.idOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Fatty liver disease scarring improved by common diabetes drug

ARYnews.tvOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

What Drove Avoro Capital Advisors' Strategic Exit from Akero Therapeutics

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Argenx: A Biotech Powerhouse Poised for Broad Expansion

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Oregon U.S. Senator Ron Wyden Leads Congressional Democrats in Fifth Circuit Fight to Protect Mifepristone Access, Women’s Health Care

Sierra Sun TimesOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

RTW Biotech Opportunities Ltd USD Revenue Breakdown – LSE:RTW

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

A grandfather struggled with treatment for late-stage pancreatic cancer — until a clinical trial helped him beat the odds

CBS NewsOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

The Trump administration’s best healthcare idea isn’t the one getting attention

americanthinker.comOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

What Does Eric Green's Retirement Mean for West Pharmaceutical Services

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Biomarin Pharmaceutical Inc. (BMRN) Q1 2026 Earnings Report - Results, Call & Slides

TipRanksOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

What's Driving Tenax Therapeutics' Recent Surge

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

What Does FDA Orphan Drug Designation Mean for Cure Rare Disease's SCA3 Treatment

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Is Vaxcyte's VAX-31 a Game-Changer in the Vaccine Landscape

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

TELCON RF PHARMACEUTICAL. Inc. Revenue Breakdown – KRX:200230

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Why is Cathie Wood Shifting from Tech to Biotech

Kavout | AIOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Millions could access cheaper monthly HIV pill under new Merck licensing deal

The Eastleigh VoiceOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Report - Results, Call & Slides

TipRanksOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical stock trades steady as investors digest stronger 2025 guidance and recent margin

AD HOC NEWSOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

6 things to know about India’s first dengue vaccine

TheHealthSiteOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Does Teva Pharmaceutical Industries (NYSE:TEVA) Still Look Undervalued After A 260% Run?

simplywall.stOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Does Teva Pharmaceutical Industries (NYSE:TEVA) Still Look Undervalued After A 260% Run?

simplywall.stOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical Inc (BMRN) Dividends & Stock Splits: Historical Payouts and Event Timeline

TradingKeyOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Fugitive doctor on run for 21 years was living as an L.A. biotech executive

KXAN AustinOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

185750 Forecast — Price Target — Prediction for 2027

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Co Ltd (0RN3) Q3 2025 Earnings Report - Results, Call & Slides

TipRanksOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma outlines path to phase 3 NEPTUNE trial of urcosimod for neuropathic corneal pain

Ophthalmology Times EuropeOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Guanhao Biotech Co., Ltd. Class A Revenue Breakdown – SZSE:300238

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Moleculin Biotech, Inc. – NASDAQ:MBRX

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Fubara’s Medical Industrial Revolution: Rivers rises as Africa’s next pharmaceutical hub

Vanguard NewsOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

US-Listed Rare Disease Biotech Hit With Full Clinical Hold; Data Unblinding Ahead

Streetwise ReportsOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical (NASDAQ:BMRN) Presents a High-Quality Breakout Setup with Strong Technical Ratings

ChartMillOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Price to sales forward of Jinling Pharmaceutical Co., Ltd. Class A – SZSE:000919

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Jinling Pharmaceutical Co., Ltd. Class A – SZSE:000919

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services, Inc. $WST Shares Sold by KBC Group NV

MarketBeatOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Tonghua Golden-Horse Pharmaceutical Industry Co. Ltd. Class A Revenue Breakdown – SZSE:000766

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Veraxa Biotech shareholders approve governance changes By Investing.com

Investing.com UKOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Pharmagreen Biotech Inc. Revenue Breakdown – OTC:PHBI

TradingViewOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Epoch Investment Partners Inc. Acquires 39,745 Shares of West Pharmaceutical Services, Inc. $WST

MarketBeatOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Is West Pharmaceutical Services Inc (WST) a Bargain After 7.7% D

GuruFocusOriginal source

🌍Jul 25discoverynews.google.comTier 3 · Aggregated media

Shaanxi Panlong Pharmaceutical Group Co., Ltd. Class A Revenue Breakdown – SZSE:002864

TradingViewOriginal source